Chlamydia trachomatis infections in norway, 1986 to 2006, surveillance data

Sexually Transmitted Diseases

Volumn 36, Issue 1, 2009, Pages 17-21

  Kløvstad, Hilde ^a   Aavitsland, Preben ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BIRTH; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; NORWAY; SEX DIFFERENCE; ADOLESCENT; HEALTH SURVEY; ISOLATION AND PURIFICATION; METHODOLOGY;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INCIDENCE; MALE; NORWAY; POPULATION SURVEILLANCE; YOUNG ADULT;

EID: 59049099393     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31818653b0     Document Type: Article

References (18)

1. Kløvstad H, Aavitsland P. Genitale chlamydiainfeksjoner i Norge 2006. MSIS rapport 2007:7.
2. Annual Epidemiological Report on Communicable Diseases in Europe. Report on the status of communicable diseases in the EU and EEA/EFTA countries. European Centre for Disease Prevention and Control; 2007.
3. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
4. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
5. Buchan H, Vessey M, Goldacre M, et al. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol 1993; 100:558-562.
6. Kløvstad H, Kloumann E, Aavitsland P. Genitale chlamydiainfeksjoner i Norge i 2005. MSIS rapport 2006:12.
7. Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis 2001; 184:1216-1219.
8. Watson EJ, Templeton A, Russell I, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: A systematic review. J Med Microbiol 2002; 51:1021-1031.
9. Løfdahl M. Klamydia i Sverige 2005. Epi Aktuelt 2006:9.
10. Klamydia 2005 Forebyggelse av klamydia. Epi-Nyt 2006:20.
11. Aavitsland P. Use of laboratory testing for genital chlamydial infection in Norway. Qual Health Care 1993; 2:91-95.
12. Aavitsland P, Lystad A. Indikasjoner for testing for seksuelt overførbare infeksjoner med Chlamydia trachomatis. Tidsskr Nor Laegeforen 1995; 115:3141-3144.
13. Bakken IJ, Nordbo SA. Chlamydia trachomatis infection in central Norway-testing patterns and prevalence. Tidsskr Nor Laegeforen 2007; 127:3202-3205 [Norwegian].
14. Burckhardt F, Warner P, Young H. What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia tracho- matis infection? Sex Transm Infect 2006; 82:24-30.
15. Bakken IJ, Skjeldestad FE, Nordbo SA. Testing pattern and prevalence of Chlamydia infections among men. Tidsskr Nor Laegeforen 2005; 125: 1634-1636 [Norwegian].
16. Bakken IJ, Skjeldestad FE, Halvorsen TF, et al. Chlamydia trachomatis among young Norwegian men: Sexual behavior and genitourinary symptoms. Sex Transm Dis 2007; 34:245-249.
17. Gotz H, Lindback J, Ripa T, et al. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis 2002; 34:28-34.
18. Fødsler i Norge 2003-2004. Asrapport/Annual report. Medisinsk fød- selsregister/Medical Birth Registry of Norway. Norwegian Institute of Public Health, Bergen, Norway; 2006.